Clinical Trial Update: Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the use of umbilical cord blood-derived mesenchymal stem cells to treat steroid-refractory acute or chronic graft-versus-h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Umbilical Cord Blood-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Samsung Medical Center | Conditions: Graft-Versus-Host Disease, GVHD | Phase 1, Phase 2 | Status: UNKNOWN